KIORA PHARMACEUTICALS, INC. Earnings Per Share (Basic)
KIORA PHARMACEUTICALS, INC. (KPRX) reported Earnings Per Share (Basic) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.34.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.58.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.01.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.54.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$2.60, a 379.57% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was $0.93.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$24.25.
- KIORA PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$18.55.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-08-07 | -$0.87 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | -$0.58 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | -$2.60 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-07 | -$1.04 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | -$0.54 10-Q · filed 2026-08-07 | -$1.10 10-Q · filed 2026-08-07 | ||||||
| 2025-03-31 | -$0.52 10-Q · filed 2026-05-08 | |||||||
| 2024-12-31 | $0.93 10-K · filed 2026-03-25 | |||||||
| 2024-09-30 | -$0.81 10-Q · filed 2025-11-07 | $2.08 10-Q · filed 2025-11-07 | ||||||
| 2024-06-30 | -$0.53 10-Q · filed 2025-08-08 | $3.19 10-Q · filed 2025-08-08 | ||||||
| 2024-03-31 | $4.67 10-Q · filed 2025-05-09 | $0.52 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | -$24.25 10-K · filed 2025-03-25 | -$2.69 10-K · filed 2024-03-25 | ||||||
| 2023-09-30 | -$7.30 10-Q · filed 2024-11-08 | -$0.89 10-Q · filed 2023-11-09 | -$23.35 10-Q · filed 2024-11-08 | -$2.73 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$7.15 10-Q · filed 2024-08-09 | -$0.79 10-Q · filed 2023-08-08 | -$15.63 10-Q · filed 2024-08-09 | -$1.74 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | -$1.00 10-Q · filed 2024-05-10 | |||||||
| 2022-12-31 | -$18.55 10-K · filed 2024-03-25 | |||||||
| 2022-09-30 | -$6.03 10-Q · filed 2023-11-09 | -$22.06 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.18 10-Q · filed 2023-08-08 | -$0.46 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | -$11.27 10-Q · filed 2023-05-09 | -$0.27 10-Q · filed 2022-07-08 | ||||||
| 2021-12-31 | -$57.12 10-K · filed 2023-03-23 | -$1.77 10-K · filed 2022-04-15 | ||||||
| 2021-09-30 | -$11.34 10-Q · filed 2022-11-09 | -$0.29 10-Q · filed 2021-11-15 | -$35.69 10-Q · filed 2022-11-09 | -$0.99 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | -$0.34 10-Q · filed 2022-08-12 | -$0.61 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.27 10-Q · filed 2022-07-08 | |||||||
| 2020-12-31 | -$1.49 10-K/A · filed 2022-07-07 | -$1.77 10-K · filed 2022-04-15 | ||||||
| 2020-09-30 | -$0.44 10-Q · filed 2021-11-15 | -$1.25 10-Q · filed 2021-11-15 | ||||||
| 2020-03-31 | -$0.43 10-Q · filed 2020-05-06 | |||||||
| 2019-03-31 | $0.30 10-Q · filed 2020-05-06 | $0.02 10-Q · filed 2019-05-08 | ||||||
| 2018-03-31 | -$0.14 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |